Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oscillococcinum in Influenza-like Illness
2013-001869-16Phase 3Completed
- Sponsor
- Boiron
- Start
- Jul 2013
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza-like illness (ILI) comparing Oscillococcinum with Placebo (2 arms). Primary endpoint: Time to absence of systemic flu-like symptoms. Started Jul 2013; status: completed.
02
Drugs
Oscillococcinum
03
Conditions
influenza-like illness (ILI)
Beyond the preview
Go deeper on 2013-001869-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001869-16.